Loading...
Chemical structure of (4R,4'R,5S,5'S)-2,2'-(Cyclopentane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)

GF51593

(4R,4'R,5S,5'S)-2,2'-(Cyclopentane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)

Also known as (4R,5S)-2-[1-[(4R,5S)-4,5-diphenyl-4,5-dihydro-1,3-oxazol-2-yl]cyclopentyl]-4,5-diphenyl-4,5-dihydro-1,3-oxazole

(4R,4'R,5S,5'S)-2,2'-(Cyclopentane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole) (catalogue number GF51593) is a research-grade chemical available from LABO Scientific in Israel, CAS registry number 2133827-34-4. Molecular formula C35H32N2O2, molecular weight 512.6408. IUPAC name: (4R,5S)-2-[1-[(4R,5S)-4,5-diphenyl-4,5-dihydro-1,3-oxazol-2-yl]cyclopentyl]-4,5-diphenyl-4,5-dihydro-1,3-oxazole. Supplied as 100mg at ₪228.42; the final price is confirmed on your quote, and the lot certificate of analysis and safety data sheet are emailed with your order confirmation.

ChemicalCAS2133827-34-4MW512.6408FormulaC35H32N2O2
CAS number
2133827-34-4
Molecular weight
512.6408
Formula
C35H32N2O2
InChIKey
WPRVHHTWEGTLPZ-ZRTHHSRSSA-N
Catalogue number
GF51593
Brand
GLPBIO
Computed properties PubChem CID 146013913 · XLogP 7.4 · TPSA 43.2 Ų · H-bond donors 0
XLogP
7.4
TPSA
43.2 Ų
H-bond donors
0
H-bond acceptors
4
Rotatable bonds
6
Heavy atoms
39

SMILES C1CCC(C1)(C2=N[C@@H]([C@@H](O2)C3=CC=CC=C3)C4=CC=CC=C4)C5=N[C@@H]([C@@H](O5)C6=CC=CC=C6)C7=CC=CC=C7

Computed descriptors from PubChem (CID 146013913), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.